Literature DB >> 18019703

Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.

Sebnem Gursoy1, Kadri Guven, Tamer Arikan, Alper Yurci, Edip Torun, Mevlut Baskol, Omer Ozbakir, Mehmet Yucesoy.   

Abstract

BACKGROUND/AIMS: Clostridium difficile is the most common cause of nosocomial infectious diarrhea. The frequency of colonization in hospitalized patients varies between 10 and 43%.
METHODOLOGY: Clostridium difficile common antigen was investigated in stool samples of 50 patients who developed nosocomial diarrhea (group 1), 65 outpatients who attended the clinic after development of diarrhea during antibiotic use (group 2), 18 patients with active chronic inflammatory bowel disease (group 3), and 30 control patients were studied. The Latex agglutination test and the toxin A was performed to investigate the presence of the Clostridium difficile common antigen in stool samples. The possible predisposing factors for nosocomial infection were analyzed.
RESULTS: Clostridium difficile common antigen was found positive in 27.7% and 14% of group 2 and group 1, respectively while negative in stools of patients with inflammatory bowel disease. Asymptomatic fecal Clostridium difficile carriage in healthy volunteers was 3.3%. The antibiotic that induced diarrhea the most was clindamycin in group 1, and ampicillin-sulbactam in group 2. Enema was found to be the most important risk factor for C. difficile in hospitalized patients.
CONCLUSIONS: The Clostridium difficile common antigen was detected more frequently in antibiotic-associated diarrhea patients than in nosocomial diarrhea patients. Clostridium difficile-associated diarrhea was also more frequent in immunosuppressive patients with uremia and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18019703

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Trends in Clostridium difficile Disease: Epidemiology and Intervention.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Med       Date:  2009

Review 2.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.

Authors:  Asiimwe Nicholas; Yu Kyung Kim; Won-Kil Lee; Gati Noble Selasi; Seok Hyeon Na; Hyo Il Kwon; Yoo Jeong Kim; Hae Sook Lee; Kyung Eun Song; Jeong Hwan Shin; Je Chul Lee
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

4.  Molecular characterization of nosocomial Clostridium difficile infection in pediatric ward in Iran.

Authors:  Abolfazl Khoshdel; Roya Habibian; Neda Parvin; Abbas Doosti; Fatemeh Famouri; Ali Eshraghi; Massoud Hafizi
Journal:  Springerplus       Date:  2015-10-19

5.  Clostridium difficile in patients with nosocomial diarrhea, Northwest of Iran.

Authors:  Yalda Hematyar; Tahereh Pirzadeh; Seyyed Reza Moaddab; Mohammad Ahangarzadeh Rezaee; Mohammad Yousef Memar; Hossein Samadi Kafil
Journal:  Health Promot Perspect       Date:  2020-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.